Comparison of Regional Block, Wound Infiltration and Caudal Block for Pain Management in Children

NCT ID: NCT05969613

Last Updated: 2023-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of regional block, wound infiltration and caudal block for post operative pain management in participants undergoing inguinal herniotomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators are comparing three modalities (regional block, wound infiltration and caudal block), for post operative pain management in participants after inguinal herniotomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Regional Block

Bupivacaine 0.25%

Group Type EXPERIMENTAL

Regional block

Intervention Type PROCEDURE

regional block with 0.25% Bupivacaine at a dose of 2ml/kg with adrenaline

Wound infilteration

Bupivacaine 0.25%

Group Type ACTIVE_COMPARATOR

Wound infiltration

Intervention Type PROCEDURE

Infiltration of surgical site with 0.25% Bupivacaine at 0.5ml/kg dose

caudal block

Bupivacaine 0.25%

Group Type ACTIVE_COMPARATOR

Caudal block

Intervention Type PROCEDURE

Infiltration of caudal epidural space with 0.25% Bupivacaine at 1ml/kg dose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Regional block

regional block with 0.25% Bupivacaine at a dose of 2ml/kg with adrenaline

Intervention Type PROCEDURE

Wound infiltration

Infiltration of surgical site with 0.25% Bupivacaine at 0.5ml/kg dose

Intervention Type PROCEDURE

Caudal block

Infiltration of caudal epidural space with 0.25% Bupivacaine at 1ml/kg dose

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. •Patients under 13 years of age
2. •Inguinal hernia

Exclusion Criteria

1. •History of allergy to any drugs used in study documented on history.
2. •Infection at the site of regional, caudal or local infiltration, documented on clinical examination.
3. •Irreducible, obstructed or strangulated hernia, documented on clinical examination.
Minimum Eligible Age

2 Months

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Edward Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatima Numeri

Dr Fatima Naumeri Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mamoonullah Asmati

Role: PRINCIPAL_INVESTIGATOR

King Edward Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Hospital

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Fnaumeri

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.